Zensun Successfully Passed the Mid-Term Evaluation of Science Prosperity Program
2007-11-13
In Sep. 4, 2007, Zensun’s ‘rhNRG-1 clinical trials and its industrialization project’ was evaluated by Science and Technology Committee of Pudong New District to pass the Mid-Term Evaluation of Science Prosperity Program.
At the end of 2005, Zensun ‘s ‘rhNRG-1 clinical trials and its industrialization project’ was elected to Shanghai Science Prosperity Projects. After about two years hard work, Zensun fulfilled the expected results.
更多动态
Zensun is Collaborating with The Leibniz-Institut für Alternsforschung-Fritz-Lipmann-Institute.V. to Conduct a Preclinical Study of Neucardin® (recombinant human Neuregulin-1) for The Treatment of Schwannomas
ZENSUN ANNOUNCES THE INVESTIGATION OF NEUCARDIN FOR CHRONIC HEART FAILURE RECEIVES FAST TRACK DESIGNATION FROM THE US FDA
An International Multi-center Phase III Clinical Trial of Recombinant Human Neuregulin-1 is going to
